Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 1781-1784, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pai, J. K.
Right arrow Articles by Rimm, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pai, J. K.
Right arrow Articles by Rimm, E. B.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2002;48:1781-1784.)
© 2002 American Association for Clinical Chemistry, Inc.


Technical Briefs

Stability of Novel Plasma Markers Associated with Cardiovascular Disease: Processing within 36 Hours of Specimen Collection

Jennifer K. Pai1,3a, Gary C. Curhan1,5, Carolyn C. Cannuscio7, Nader Rifai6,8, Paul M. Ridker3,4,6 and Eric B. Rimm1,2,5

Departments of
1 Epidemiology and
2 Nutrition, Harvard School of Public Health, Boston, MA 02115
Divisions of
3 Preventive Medicine and
4 Cardiology,
5 Channing Laboratory, Department of Medicine, and
6 Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115
7 Merck & Co., Inc., West Point, PA 19422

8 Department of Pathology, Children’s Hospital Medical Center and Harvard Medical School, Boston, MA 02115

aaddress correspondence to this author at: Harvard School of Public Health, Department of Epidemiology, 677 Huntington Ave., 9th Floor, Kresge Bldg., Boston, MA 02115; fax 617-566-7805, e-mail jpai@hsph.harvard.edu

The first 300 words of the full text of this article appear below.

Plasma markers are ideally measured prospectively because marker concentrations may change after diagnosis with disease. In many large prospective studies, such as the Nurses’ Health Study (1) and Health Professionals Follow-up Study (2), blood samples are collected, placed on ice, and mailed back to the central laboratory for processing via overnight or next-day mail service. Because economic constraints typically lead researchers to collect only one sample per study participant (3)(4), it is important to determine the time frame within which markers remain stable and to optimize the methods for handling and processing the sample. Although many studies have examined marker stability after long-term storage, few studies have assessed the impact of transport conditions on whole blood not immediately processed.

We selected a series of lipid and novel inflammatory markers whose concentrations have been shown or have been suspected to influence the risk of cardiovascular disease: C-reactive protein (CRP), fibrinogen, lipoprotein (a) [Lp(a)], apolipoprotein B (apoB), intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), p-selectin, von Willebrand factor (vWf), oxidized LDL (oxLDL), anti-cardiolipin antibodies (aCLAbs), tumor necrosis factor receptors I and II (TNF-RI and TNF-RII), and matrix metalloproteinase-1 (MMP-1) (5)(6)(7)(8)(9)(10)(11)(12)(13). The purpose of this study was to evaluate the stability of selected novel markers of cardiovascular disease under time and temperature conditions that simulated sample transport by mail for up to 36 h before processing.

We included 17 premenopausal women, 25–45 years of age, who had responded to a recruitment advertisement. Blood samples were collected from each woman into three 15-mL Vacutainers containing sodium heparin and placed on ice until processing. The time to processing was defined as the time from when the samples . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Eur Heart JHome page
R. Cangemi, L. Loffredo, R. Carnevale, L. Perri, M. P. Patrizi, V. Sanguigni, P. Pignatelli, and F. Violi
Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E
Eur. Heart J., January 1, 2008; 29(1): 54 - 62.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Hartweg, M. Gunter, R. Perera, A. Farmer, C. Cull, C. Schalkwijk, A. Kok, H. Twaalfhoven, R. Holman, and A. Neil
Stability of Soluble Adhesion Molecules, Selectins, and C-Reactive Protein at Various Temperatures: Implications for Epidemiological and Large-Scale Clinical Studies
Clin. Chem., October 1, 2007; 53(10): 1858 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. K. Pai, J. E. Manson, K. M. Rexrode, C. M. Albert, D. J. Hunter, and E. B. Rimm
Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women
Eur. Heart J., June 1, 2007; 28(11): 1297 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
M Wildgruber, W Weiss, H Berger, H-H Eckstein, O Wolf, and P Heider
Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery a pilot study
Br. J. Radiol., June 1, 2007; 80(954): 430 - 436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Lopez-Garcia, R. M van Dam, L. Qi, and F. B Hu
Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 888 - 893.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Wu, W. C. Willett, N. Rifai, I. Shai, J. E. Manson, and E. B. Rimm
Is Plasma Oxidized Low-Density Lipoprotein, Measured With the Widely Used Antibody 4E6, an Independent Predictor of Coronary Heart Disease Among U.S. Men and Women?
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 973 - 979.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. B. Link and J. S. Jacobson
Effect of delayed processing on high-sensitivity C-reactive protein.
Clin. Chem., April 1, 2006; 52(4): 787 - 788.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. K Jensen, P. Koh-Banerjee, M. Franz, L. Sampson, M. Gronbaek, and E. B Rimm
Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. J. Mukamal, M. K. Jensen, M. Gronbaek, M. J. Stampfer, J. E. Manson, T. Pischon, and E. B. Rimm
Drinking Frequency, Mediating Biomarkers, and Risk of Myocardial Infarction in Women and Men
Circulation, September 6, 2005; 112(10): 1406 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Shai, E. B. Rimm, S. E. Hankinson, C. Cannuscio, G. Curhan, J. E. Manson, N. Rifai, M. J. Stampfer, and J. Ma
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
Eur. Heart J., August 2, 2005; 26(16): 1633 - 1639.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Meisinger, J. Baumert, N. Khuseyinova, H. Loewel, and W. Koenig
Plasma Oxidized Low-Density Lipoprotein, a Strong Predictor for Acute Coronary Heart Disease Events in Apparently Healthy, Middle-Aged Men From the General Population
Circulation, August 2, 2005; 112(5): 651 - 657.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
I. Shai, M. B. Schulze, J. E. Manson, K. M. Rexrode, M. J. Stampfer, C. Mantzoros, and F. B. Hu
A Prospective Study of Soluble Tumor Necrosis Factor-{alpha} Receptor II (sTNF-RII) and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes
Diabetes Care, June 1, 2005; 28(6): 1376 - 1382.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Lopez-Garcia, M. B. Schulze, J. B. Meigs, J. E. Manson, N. Rifai, M. J. Stampfer, W. C. Willett, and F. B. Hu
Consumption of Trans Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Dysfunction
J. Nutr., March 1, 2005; 135(3): 562 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. T. van der Schouw, L. Sampson, W. C. Willett, and E. B. Rimm
The Usual Intake of Lignans but Not That of Isoflavones May Be Related to Cardiovascular Risk Factors in U.S. Men
J. Nutr., February 1, 2005; 135(2): 260 - 266.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. K. Pai, T. Pischon, J. Ma, J. E. Manson, S. E. Hankinson, K. Joshipura, G. C. Curhan, N. Rifai, C. C. Cannuscio, M. J. Stampfer, et al.
Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
N. Engl. J. Med., December 16, 2004; 351(25): 2599 - 2610.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Shai, E. B. Rimm, S. E. Hankinson, G. Curhan, J. E. Manson, N. Rifai, M. J. Stampfer, and J. Ma
Multivariate Assessment of Lipid Parameters as Predictors of Coronary Heart Disease Among Postmenopausal Women: Potential Implications for Clinical Guidelines
Circulation, November 2, 2004; 110(18): 2824 - 2830.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. L. Knight, E. B. Rimm, J. K. Pai, K. M. Rexrode, C. C. Cannuscio, J. E. Manson, M. J. Stampfer, and G. C. Curhan
Kidney Dysfunction, Inflammation, and Coronary Events: A Prospective Study
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1897 - 1903.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Lopez-Garcia, M. B. Schulze, J. E. Manson, J. B. Meigs, C. M. Albert, N. Rifai, W. C. Willett, and F. B. Hu
Consumption of (n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in Women
J. Nutr., July 1, 2004; 134(7): 1806 - 1811.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
D. Mozaffarian, T. Pischon, S. E Hankinson, N. Rifai, K. Joshipura, W. C Willett, and E. B Rimm
Dietary intake of trans fatty acids and systemic inflammation in women
Am. J. Clinical Nutrition, April 1, 2004; 79(4): 606 - 612.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Pischon, S. E. Hankinson, G. S. Hotamisligil, N. Rifai, W. C. Willett, and E. B. Rimm
Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women
Circulation, July 15, 2003; 108(2): 155 - 160.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. J. Giltay, J. M. Geleijnse, E. G. Schouten, M. B. Katan, and D. Kromhout
High Stability of Markers of Cardiovascular Risk in Blood Samples
Clin. Chem., April 1, 2003; 49(4): 652 - 655.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.